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Abstract: Bartonella bacilliformis is the bacterial agent of
Carrión’s disease and is presumed to be transmitted
between humans by phlebotomine sand flies. Carrión’s
disease is endemic to high-altitude valleys of the South
American Andes, and the first reported outbreak (1871)
resulted in over 4,000 casualties. Since then, numerous
outbreaks have been documented in endemic regions,
and over the last two decades, outbreaks have occurred at
atypical elevations, strongly suggesting that the area of
endemicity is expanding. Approximately 1.7 million South
Americans are estimated to be at risk in an area covering
roughly 145,000 km2 of Ecuador, Colombia, and Peru.
Although disease manifestations vary, two disparate
syndromes can occur independently or sequentially. The
first, Oroya fever, occurs approximately 60 days following
the bite of an infected sand fly, in which infection of
nearly all erythrocytes results in an acute hemolytic
anemia with attendant symptoms of fever, jaundice, and
myalgia. This phase of Carrión’s disease often includes
secondary infections and is fatal in up to 88% of patients
without antimicrobial intervention. The second syndrome,
referred to as verruga peruana, describes the endothe-
lialcell-derived, blood-filled tumors that develop on the
surface of the skin. Verrugae are rarely fatal, but can bleed
and scar the patient. Moreover, these persistently infected
humans provide a reservoir for infecting sand flies and
thus maintaining B. bacilliformis in nature. Here, we
discuss the current state of knowledge regarding this
life-threatening, neglected bacterial pathogen and review
its host-cell parasitism, molecular pathogenesis, phyloge-
ny, sand fly vectors, diagnostics, and prospects for control.
Methods
Authors were included based upon their relevant expertise in
the field. Available databases were searched with key words for
applicable articles in both English and Spanish. All cited work was
previously peer-reviewed and published elsewhere.
Janus: The Two Faces of Carrión’s Disease
A brief history
Bartonellosis, or Carrión’s disease, is a remarkable bi-phasic
illness that manifests as either angiogenic lesions that occur
primarily on the skin or as a severe hemolytic anemia. It is caused
by Bartonella bacilliformis, a bacterium presumed to be transmit-
ted between humans through bites of infected female phleboto-
mine sand flies, most notably Lutzomyia verrucarum [1–4].
Humans are the only known reservoir. Carrión’s disease is
endemic to arid, high-altitude (approximately 600–3200 m) valleys
in the Andes Mountains of Peru, Ecuador, and Colombia [5–10],
coincident with the habitat of the sand fly vector [5]. Evidence for
bartonellosis in the region predates Columbus. Skin lesions akin to
those typical of bartonellosis are depicted on 2,000-year-old pre-
Inca ceramics, and Bartonella-like bacteria have been observed in
skin lesions taken from the mummified remains of a human
sacrifice victim who died over 1,000 years ago [11]. Descriptions
of these lesions, referred to as verruga peruana (VP), appear in the
journals of Spanish conquistadors who arrived in South America
during the 16th century, and in 1630, Gago de Vadillo published
the first medical treatise on the disease [12].
Two events inexorably linked with the early history of
bartonellosis occurred within 15 years of one another at the end
of the 19th century. The first was a dramatic outbreak of
hemolytic anemia among workers based in the upper Rimac
valley, above Lima, during the construction of a railway line to the
mining town of La Oroya in 1871. During the course of a few
weeks at least 4,000 men died of what became known as Oroya
Fever (OF), although the agent of the syndrome remained elusive.
Second, the common etiology of OF and VP was revealed when,
in 1885, a medical student named Daniel Carrión injected himself
with exudate from a verruga lesion, then developed OF and died
[12]. Carrión sacrificed his life to establish the common etiology of
VP and OF and is one of the most heroic figures in Peruvian
medical history. In honor of his contribution, South American
bartonellosis is commonly known as Carrión’s disease. Finally, in
1905, Alberto Barton solved the riddle of the etiological agent of
Carrión’s disease when he observed intracellular bacteria in blood
smears from Oroya fever patients. These bacteria were subse-
quently named Bartonella bacilliformis in his honor.
Carrión’s disease is most common in Peru, where nearly all
cases have occurred over the last 70 years in the Departments of
Ancash, Cajamarca, Cuzco, Lima, and Amazonas [13]. Sporadic
cases may have also occurred in Chile, Bolivia, and Guatemala
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[14]. During the last two decades, several outbreaks have occurred
at abnormal altitudes and in historically nonendemic regions of
Ecuador, Colombia, and Peru (e.g., near sea level in Huaral and
Ica, Peru [13,15]; the Utcubamba River Valley in Amazonas [16];
Urubamba Valley and Sacred Valley of the Incas near Cuzco
[17,18]; and the high Amazonas jungle [19]). In addition, multiple
outbreaks have occurred concurrently in endemic regions (e.g.,
Ancash Region, Peru; Zamora-Chinchipe Province, Ecuador) [5–
8,20,21]. Children have been hardest hit by these outbreaks, with
fatality rates of approximately 10% [13,15,22]. A 10-fold increase
in cases (948 to 10,390) was reported in Peru from 1997–2005
[23], with 52 cases per 100,000 Peruvians in 1999 [13]. Reported
rates are considerably higher in endemic regions of Peru, at 242
cases per 100,000 inhabitants (http://www.dge.gob.pe/). An
estimate of the at-risk population for Carrión’s disease is 1.7
million people in an area of 145,000 km2 [15]. In one prospective
cohort study of a Peruvian community in an endemic area, an
incidence rate of 12.7 per 100 person-years was estimated,
reflecting a clustering of 70% of cases within 18% of homes [24].
Factors contributing to the emergence and geographical expan-
sion of B. bacilliformis are unclear but include climatic events that
favor sand fly propagation, such as increased temperature,
humidity, and rainfall during El Niño cycles [21,25,26], and
possibly additional sand fly species serving as competent vectors (see
‘‘Sand fly vectors,’’ below) [5,27–29]. In short, Carrión’s disease is a
reemerging public health threat in several South American nations
and to travelers who visit these countries [10,30].
Oroya fever (OF)
Carrión’s disease manifests as two distinct syndromes that occur
independently or sequentially. The first phase, OF (also known as
the acute, primary or hematic phase), is more common in children
(.60% of cases [13,22,31]) in both endemic and nonendemic
areas, and it is characterized by an acute bacteremia at about 60
days (range of 10–210 days; [32]) following the bite of an infected
sand fly. From the inoculation site, B. bacilliformis colonizes the
entire circulatory system, and nearly every erythrocyte is infected
(Figure 1A). OF involves a severe reduction in hematocrit (.80%
destruction) and acute hemolytic anemia from splenic culling of
infected erythrocytes [33–35]. Patients with OF present for 1–4
weeks with an array of symptoms, including pallor, fever,
anorexia, malaise, cardiac murmur, myalgia, headache, jaundice,
tachycardia, and hepatomegaly. Complications are common
during OF, and include high mortality in pregnant women and
their unborn children, cardiovascular and neurological problems,
respiratory infections, and arthralgia [22,36]. This phase of disease
can be fatal in 40%–88% of infected patients without antimicro-
bial intervention [2,5,12,14,32,36,37] and is by far the highest
reported case-fatality rate for any Bartonella species. Secondary
infections are also common and potentially life-threatening, and
they may arise due to an immune-compromised state that
accompanies the disease. These include salmonellosis, toxoplas-
mosis, malaria, shigellosis, histoplasmosis, and pneumocystosis
[5,14,37]. Even with appropriate antimicrobial therapy, fatality
rates of 9%–11% are typical [13,15,38]. A milder form of OF has
also been reported with a significantly lower case-fatality rate
(0.7%), suggesting that virulence potential and associated disease
severity may be strain-dependent [16]. Bartonella rochalimae, a
distantly related Bartonella species isolated from a tourist who
visited South America has been reported to cause a relatively mild
febrile illness that could be confused with OF. Although associated
symptoms are similar, no intraerythrocytic bacteria are observed
in blood smears and there is only a slight drop in hematocrit and
mild anemia [39].
Figure 1. Clinical manifestations of Carrión’s disease. (A) Erythrocyte infection during OF, as observed in a blood smear stained with Wright’s
stain (reprinted by permission from [203]). (B) VP lesions on a child in Peru (reproduced from Future Microbiology 4(6): 743–758 (2009) with
permission of Future Medicine, Ltd).
doi:10.1371/journal.pntd.0002919.g001
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Verruga peruana (VP)
The second syndrome (also known as the tissue, chronic, or
eruptive phase) involves blood-filled nodular hemangiomas of the
skin, termed VP or Peruvian warts (Figure 1B). Tissue involvement
results from bacterial invasion of capillary endothelium and generates
bacteria-filled vacuoles, termed Rocha Lima inclusions, and localized
cellular proliferation, leading to formation of VP [40] (see ‘‘Angio-
genesis,’’ below). Verrugae are cutaneous and usually occur on the
head and extremities, where they can persist for several weeks to
months. Lesions are classified as miliary (multiple red papules of ,
3 mm in diameter), mular (blood-filled nodules), and diffuse (groups
of subdermal nodules .5 mm in diameter) [32]. Although OF occurs
at a lower frequency, the eruptive phase is a more common
manifestation in inhabitants of endemic regions [16]. The higher
incidence of verruga in endemic areas likely reflects the immune
status of the population (see ‘‘Host immune response, protection,’’
below). In cases of sequential illness, patients erupt with verrugae
roughly 4–8 weeks after resolving OF [41]. VP is rarely fatal, but
lesions can bleed or scar the patient, and eruptions can be
accompanied by fever and malaise, lymphadenopathy, acute bone
and joint pains, headache, and a chronic Bartonella infection
[2,22,32]. The recent discovery of a new Bartonella taxon, referred to
as Candidatus Bartonella ancashi, as the etiological agent of persistent
bacteremia and VP in a three-year-old boy living near Caraz, Peru,
indicates that species other than B. bacilliformis may be responsible
for some chronic bartonellosis cases in endemic areas [42]. Whether
Candidatus Bartonella ancashi can cause OF is unknown.
Sand fly vectors
B. bacilliformis is believed to be transmitted by bites of
phlebotomine sand flies to humans living in the high mountain
valleys of Peru and neighboring countries of Andean South
America. Townsend was the first to advance this view, and he
identified Phlebotomus verrucarum (now L. verrucarum) as the
vector of ‘‘Verruga’’ [43–45]. Experiments by Townsend and
other workers provided strong circumstantial evidence of sand fly
vectorship but no conclusive proof.
Having the suspicion based on circumstantial evidence that a
suspected vector insect transmits a specific pathogen to man or
other animals does not constitute incrimination. One must
determine the role the insect plays in the natural history of the
pathogen. Killick-Kendrick and Ward [46] outlined five criteria
that must be fulfilled to declare with reasonable certainty that a
sand fly is a vector of human disease. Applied to the transmission
of B. bacilliformis, these are:
1. The suspected vector sand fly must bite humans and be present
in a place where humans become infected with B. bacilliformis.
2. The distribution of the suspected vector should encompass the
distribution of the disease in humans, and the sand fly must be
sufficiently abundant to maintain pathogen transmission.
3. B. baciliformis should be isolated from wild-caught sand flies
and be shown to be indistinguishable from the pathogen
causing disease in humans in the same area.
4. It should be demonstrated that naturally or experimentally
infected flies can maintain the infection through the complete
extrinsic life cycle of the pathogen.
5. Experimental transmission of B. bacilliforms by bite or some
other means would generally be considered conclusive proof
that a sand fly is a vector of a given pathogen.
Of these criteria, the first two are fairly easy to satisfy through
observations of sand fly behavior in the field, and numerous
workers have done so. The remaining three criteria are more
difficult to satisfy and must be accomplished through painstaking
analysis and experimentation to conclusively incriminate a sand fly
species as a vector of B. bacilliformis.
Beginning in 1926, Noguchi and associates conducted several
experiments in which triturated, wild-caught sand flies from the
‘‘Verruga zone’’ in Peru were inoculated into monkeys to produce
infection [47,48]. Around the same time, Battistini performed a
series of experiments in which sand flies collected from the
Verruga zone were released into a screened cage with a rhesus
monkey. Although this was the first sand fly experiment in which
the disease was transmitted by means other than inoculation, the
sand flies were not observed and it was not determined whether
transmission was by bite [49–51]. Between 1937 and 1939, Hertig
and associates conducted several feeding experiments in which
wild-caught sand flies were either released into small cages with a
rhesus monkey, or placed in small feeding cages and strapped to
the monkey’s shaved belly. Five monkeys became infected as
determined by blood culture but no cultures were made from the
sand flies [1]. Furthermore, uncertainty remained as to whether
transmission was by bite or some other means such as by
defecation, as ‘‘… there existed opportunities for other types of
contact than that of the mouthparts between sand fly and monkey,
such as the deposit of fecal matter if such there should be’’ [1].
Later, these scientists isolated what they said was B. bacilliformis
from the proboscis of each of two ‘‘Phlebotomus verrucarum’’ (L.
verrucarum) collected from an epidemic focus at Huinco in the
Santa Eulalia Valley [1]. Because culture methods used at that
time were likely not sufficiently refined to distinguish between B.
bacilliformis and other Bartonella species, there is a lingering
question as to whether this was the same pathogen causing disease
in humans. However, it is fair to say that Hertig’s team was the
first to incriminate L. verrucarum as a vector of B. bacilliformis.
Attempts to culture B. bacilliformis from sand fly guts were
unsuccessful; hence, they were unable to demonstrate any
developmental cycle in the sand fly that might explain the
mechanism of transmission [1].
In preliminary experiments conducted recently by three of the
authors (MFM, JMB, and PGL), L. verrucarum from a laboratory
colony (Walter Reed Army Institute of Research) were fed through
a chick-skin membrane on human blood containing green
fluorescent protein (GFP)-labeled B. bacilliformis. Serial dissec-
tions of putatively infected flies and microscopic examination of
their guts under UV over seven days revealed massive proliferation
of the bacteria within the blood meal and invasion of red blood
cells during the first three days (Figure 2). The infection persisted
for at least seven days in the gut of the sand fly. Contrary to what
Hertig observed [1], no B. bacilliformis were seen on the
mouthparts or in any organ other than the midgut. Diuretic
droplets deposited on glass cover slips following feeding contained
no labeled bacteria, an indication that posterior station transmis-
sion via diuresis is unlikely. Transmission by bite during a second
blood meal was not attempted, nor were fecal droplets from the
digested blood meal examined for B. bacilliformis contamination.
The mechanism of transmission of B. bacilliformis by sand flies is
still unclear and is the subject of ongoing investigations.
Other vector sand flies. Owing to discrepancies between
the distribution of Carrión’s disease and L. verrucarum, the
existence of secondary vectors was suggested [27]. Whereas L.
verrucarum is limited to altitudes below approximately 3,200 m
above sea level L. peruensis has been collected in human
habitations in endemic villages as high as 3,740 m ASL [27;
2005, Wilfredo Arque, unpublished data, personal communica-
tion]. Since Hertig’s landmark experiments, substantial evidence
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has accumulated in Peru to also incriminate L. peruensis, which is
highly anthropophilic and abundant or dominant in bartonellosis
foci in Ancash and Cusc departments, respectively. In studies
conducted during an outbreak in the Urubamba Valley, L.
peruensis in large numbers and a few L. pescei were the only sand
fly species found. B. bacilliformis was identified using PCR in 2%
of L. peruensis analyzed [17]. In two other foci in Peru, 2%–8% of
pools of L. verrucarum collected from patient houses in the Caraz
area, Ancash Department, and 2% of pools of L. peruensis
collected from patient houses in villages 70 km south of Cusco,
Cusco Department were PCR positive for B. bacilliformis (2005,
Sofia Romero, unpublished data, personal communication).
Besides L. verrucarum and L. peruensis, several other sand fly
species are suspected vectors of B. bacilliformis. Caceres et al.,
working in the Peruvian provinces of Jaen, San Ignacio and
Utcubamba, found L. robusta and L. maranonensis in great
abundance in intradomiciliary habitats and, because of the
absence of L. verrucarum and L. peruensis, considered these as
likely vectors of B. bacilliformis in associated foci [28]. Elsewhere,
on the eastern slope of the Andes in what is known as ‘‘Yungas,’’
or high jungle, Tejada et al. found that L. serrana, an avid man-
biter, comprised 93.6% of sand flies collected during an
investigation of a bartonellosis outbreak in Huamalı́es, Huánuco
Department [52].
In neighbor Andean countries of Colombia and Ecuador, where
L. verrucarum and L. peruensis are absent, other species are
suspected as vectors, but insufficient evidence has been produced
to implicate them with certainty. Dominant species in Colombian
districts where human bartonellosis has been reported, include L.
gomezi, L. panamensis, and L. serrana, all of which are
anthropophilic but none of which has ever been associated with
B. bacilliformis transmission [6]. L. colombiana is considered the
most likely vector of B. bacilliformis in Colombia based on its
highly anthropophilic behavior and occurrence in all three
departments of the country from which bartonellosis outbreaks
have been reported [6]. The species that transmits this pathogen in
Ecuador remains unknown [6].
Spatial and temporal dynamics of vector sand
flies. Three-year longitudinal studies of suspected vector sand
flies associated with bartonellosis outbreaks in Ancash and Cusco
departments of Peru revealed that both L. verrucarum and L.
peruensis exhibit unimodal annual temporal distribution patterns
with lowest population densities occurring in June and July,
corresponding to the ‘‘winter’’ dry season; and highest population
Figure 2. B. bacilliformis infection of a phlebotomine sand fly. (A) Female L. verrucarum at 16 h post-feeding with an artificial blood feeder
containing human blood and GFP-expressing B. bacilliformis (low-passage strains 14866 and 14868). (B) Light micrograph of L. verrucarum midgut at
five days post-feeding on human blood containing GFP+ B. bacilliformis. Central brown area is residual blood meal. (C) Corresponding UV light
micrograph of (B). Note the GFP+ B. bacilliformis in residual blood meal and elsewhere in the midgut.
doi:10.1371/journal.pntd.0002919.g002
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densities in November, prior to the onset of the ‘‘summer’’ rainy
season in December (Figure 3) [53]. It was further determined that
sand fly population densities are directly correlated with average
minimum ambient temperatures and relative humidity (Figure 3)
[53]. As nighttime temperatures and relative humidity increase,
sand fly activity also increases (Figure 4) [53]. These findings are
consistent with the notion that the height of the B. bacilliformis
transmission season, March to May, [24,26] corresponds to the
descending side of the seasonal sand fly population peak, February
to June, when the aggregate population is oldest and when the
highest percentage of flies have had an opportunity to take at least
one blood meal and are thus more likely to be infected.
In the Ancash and Cusco regions of Peru, approximately 80%
of the flies were captured inside case houses, mostly in sleeping
quarters, and 35%–40% of females were blood-fed. Being weak
fliers, sand flies breed in close proximity to their blood-meal
source, feeding at dusk and during the evening, when ambient
temperatures drop and relative humidity rises [53]. L. verrucarum
and L. peruensis both rest inside human dwellings and feed
readily indoors, preferentially on humans [24,53]. Results of
bloodmeal analyses conducted in an endemic focus of cutaneous
leishmaniasis in Chaute, Lima, showed that L. peruensis is more
anthropophilic than is L. verrucarum [54]. It was also shown that
multiple-host blood meals are common, including bloodmeals
containing blood from animals only present within the houses
mixed with blood from animals only present in nearby shelters,
indicating movement of flies from animal shelters to the houses
(or vice versa) to finish feeding. People living in endemic villages
Figure 3. Monthly sand fly collection results from three villages in the Cusco Region, Peru. Results show a unimodal annual population
distribution pattern with: (A) corresponding mean morning (blue line) and evening (pink line) temperatures and (B) corresponding mean morning
(green line) and evening (red line) relative humidity. Collections were made during two nights per month at case homesteads from March 2001 to
August 2004. The data gap between October 2001 and January 2002 is due to a cessation of activity mandated by the Peruvian Ministry of Health.
doi:10.1371/journal.pntd.0002919.g003
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report that the sand fly bites occur indoors during the evening,
directly before and during the hours of sleep, further confirming
that transmission occurs inside the home during the evening and
the night [24].
As entomological field studies have shown, vectors of
infectious diseases, including vectors of bartonellosis, are
sensitive to temperature, humidity, wind, and rainfall patterns;
therefore, their abundance is influenced by climate variability
[24,26]. During the El Niño weather event that occurred in
Peru during late 1997 through mid-1998 weather cycles, the
rainy season was extended, and the humidity and minimum
monthly temperatures rose. This climatic anomaly allowed
potential vector populations to flourish, and unusually high
numbers of sand flies were collected [24,26]. The net result was
that major epidemics of bartonellosis erupted in Peru, especially
in Caraz and Cusco areas. The impact of weather extremes on
vector sand fly ecology and transmission of B. bacilliformis
warrants thorough study [26].
Host Cell Parasitism, Angiogenesis, and Immune
Response
Colonization of the host: How, when, and where
Bartonella species infect an array of mammals with species
specificity for their natural reservoir host(s); humans generally
serve as incidental hosts. Notable exceptions include B. bacilli-
formis (human reservoir) and B. quintana (found in humans and
nonhuman primates [55]). Infection of reservoir mammals is
generally subclinical with persistent intraerythrocytic bacteremia.
Bartonella are typically inoculated directly into blood by the bite
of an arthropod vector such as fleas, ticks, and sand flies or
indirectly when feces of the vector are scratched into the skin. B.
henselae can also be transmitted via the scratch of a contaminated
cat claw. The persistence of bartonellae in the natural host
facilitates uptake and transmission by hematophagous arthropod
vectors. Colonization of the host’s lymphatics and circulatory
system may be enhanced by blood flow and perhaps motility in
Figure 4. Results of collection-bottle-rotator (CBR) trap collections of sand flies in Peru. Results show that: (A) nightly sand fly activity is
limited to early evening (1800–2000 hrs) from March through July, the coldest part of the year, which represents the Peruvian winter, and (B) as
nighttime temperatures increase in late August through November (late winter and spring), sand fly activity extends throughout the night. ‘‘Inside’’
and ‘‘outside’’ refer to trap locations within and outside a domicile, respectively.
doi:10.1371/journal.pntd.0002919.g004
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flagellated species. For example, B. bacilliformis are highly motile
by lophotrichous flagella (Figures 5 and 6), appendages consisting
of approximately 42 kDa flagellin subunits that are resistant to
protease treatment [56].
Adherence to host cells
Bartonella infections involve interactions with both nucleated
cells and erythrocytes. While erythrocyte adherence by different
bartonellae is known to be host-specific, adhesion to nucleated
cells is considered to be relatively generic. B. bacilliformis invades
a variety of human cell types, including endothelial cells, dermal
fibroblasts, and laryngeal epithelium [57]. Similarly, B. henselae
and B. quintana have been shown to adhere and invade diverse
human cell types, including epithelial cells [58], endothelial cells
[59,60], and macrophages [61]. In each case, trimeric auto-
transporter adhesin proteins (TAAs) are thought to play a leading
role in adherence to nucleated host cells [62,63].
B. bacilliformis possesses three brp genes encoding Bartonella repeat
proteins (Brps) [64]. These proteins, along with Bartonella adhesin A
(BadA) of B. henselae and variably expressed outer membrane proteins
(Vomps) of B. quintana, belong to the TAA family of type V secretion
systems [62,63]. BadA is the best-understood Bartonella adhesin and
consists of surface filaments with head, neck, and repetitive stalk
domains assembled on a C-terminal anchor [65]. BadA’s head is crucial
for host cell interactions and triggering a proangiogenic response [66].
Although Bartonella TAAs share remarkable features and functional
similarities, they vary considerably in size, and multiple gene variants
are often found in the genome [67]. There are at least two variants of
the badA gene in B. henselae, and four genes encode the Vomps of B.
quintana (vompA–vompD) [63]. B. bacilliformis Brps share common
domains and structural features with TAAs (reviewed in [64]).
The role of BadA has been well studied in B. henselae, where it
is essential for autoagglutination, adhesion to host cells, and
extracellular matrix proteins such as fibronectin and collagens,
inhibition of phagocytosis, and induction of a proangiogenic
response in host cells [62,68,69]. The Vomps of B. quintana have
also been shown to play a similar role in host cell interaction and
autoagglutination [63,70,71]. Thus, while the biological role of B.
bacilliformis Brps has not yet been investigated, it is plausible that
the Brps play similar roles in pathogenesis.
Erythrocytes are another major target cell during bartonelloses.
Optimal adherence to erythrocytes by B. bacilliformis occurs in
vitro at approximately six hours after co-incubation [34] and is
thought to be energy-dependent [72]. Studies have shown that B.
bacilliformis and B. henselae recognize five or six proteins,
respectively, of human erythrocyte membranes [73]. A polar tuft
of fibrous projections resembling peritrichous flagella on B.
bacilliformis was observed to make contact with the erythrocyte
membrane during adhesion [72], and antiserum to flagella was
shown to significantly reduce B. bacilliformis association with red
cells as compared to controls [56]. These data suggest that flagella
may possess adhesive qualities and/or increase bacteria–host cell
collisions. It has been proposed that Trw T4SS and flagella
expression are mutually exclusive phenotypes (Figure 6), and the
Trw system replaces the erythrocyte adhesion role of flagella among
non-flagellated Bartonella [74]. Specifically, TrwL and TrwJ
adhesins have been shown to result in adherence to erythrocytes.
TrwJ1 and TrwJ2 were shown to localize to the bacterial cell surface
and serve as species-specific adhesins for erythrocytes [75,76].
Invasion of host cells
Bartonella species are facultative intracellular bacteria, and
growth within host cells is typical. Virulence studies with B.
bacilliformis and cultured epithelial or endothelial cell monolayers
demonstrated that the bacterium can induce host cells to
reconfigure the cytoskeleton and enhance uptake. Internalization
Figure 5. Transmission electron micrographs showing morphology of B. bacilliformis. Bacteria were grown three days on heart infusion
agar containing 4% sheep erythrocytes and 2% sheep serum at 30uC and 100% relative humidity. Cells were subsequently fixed in 2% glutaraldehyde
in cacodylate (pH 7.2), epoxy embedded by standard methods, then sectioned and stained with uranyl acetate (UA) and lead citrate stains.
Micrographs show B. bacilliformis (strain KC583): (A) from a thin section; (B) applied directly to a grid stained with UA to show flagella. Scale bars
represent 100 nm in (A) and 500 nm in (B).
doi:10.1371/journal.pntd.0002919.g005
PLOS Neglected Tropical Diseases | www.plosntds.org 7 July 2014 | Volume 8 | Issue 7 | e2919
is significantly reduced (approximately 30% of untreated controls)
if actin filament formation is inhibited with cytochalasin D, or if
bacteria are pre-treated with anti-B. bacilliformis antibodies [57].
These inhibition studies indicate that the bacterium plays an active
role during internalization and the process involves a surface-
exposed molecule(s) that is accessible to antibody.
Parasitism of erythrocytes (hemotrophy) is an uncommon
strategy practiced by a handful of bacterial pathogens, including
Figure 6. Genomic structure of seven Bartonella chromosomes. (A) Chromosomes (Chr) are arranged in size from largest (B. tribocorum) to
smallest (B. bacilliformis). Plasmid (Pla) sizes are listed, if present. B. quintana’s genome encodes the least number of proteins (1,142), and B.
clarridgeiae has the lowest GC% (35.7%). Several virulence-related ORFs have been used to infer phylogeny (fla – vbh) and black circles indicate their
presence in a particular species. (B) Multiple alignment of seven complete genomes using pM. Location, orientation and position of locally collinear
syntenic blocks (LCBs) shared amongst all chromosomes are color-coded and connected by lines. User can analyze location, orientation, and size of
LCBs in multiple chromosomes simultaneously (red arrowheads). Local rearrangements, duplications, and inversions are easily identified.
Abbreviations correspond to the Bartonella species shown in (A).
doi:10.1371/journal.pntd.0002919.g006
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Bartonella and Anaplasma species and Mycoplasma haemofelis
[77]. Hemotrophy is thought to satisfy the absolute requirement of
bartonellae for hemin. Erythrocyte invasion by bartonellae is
markedly different than entry into other cell types, because red
cells are passive, non-endocytotic, and cannot contribute to
internalization. Early work showed that three determinants were
important for erythrocyte invasion by B. bacilliformis, including
deformin, flagella, and proteins encoded by an invasion-associated
locus (ialAB).
Deformin is an extracellular factor that generates trenches and
pits in erythrocyte membranes (Figure 7) that resemble those seen
on infected red cells [34]. The invaginations are thought to
provide entry portals for bacterial colonization. However, even
with deformin, bacteria must be motile to access the cytosol [78].
Initial studies showed that deformin was a secreted, homodimeric
protein (130 kDa in its native state). Activity was enhanced by
pretreatment of erythrocytes with trypsin or neuraminidase and
abrogated if cells were pretreated with phospholipase D.
Deformin-induced invaginations were reversible by treatment
with vanadate or dilauroyl phosphatidylcholine (DLPC), or if
intracellular Ca2+ levels were increased with ionophores [78,79].
Subsequent work contradicted earlier results and showed that
deformin was a small, hydrophobic molecule of approximately
1400 Da with high affinity for albumin [80]. Finally, a third study
implicated a set of 36 kDa proteins in the culture supernatant as
being required for maximal activity [81]. Despite these discrepant
observations, the nature of deformin and its role in hemotrophy
warrant further investigation, especially considering the marked
morphological changes the factor produces in erythrocyte
membranes.
Flagellum-mediated motility also appears to play an important
role in hemotropy. If B. bacilliformis is treated with antiflagellin
antibodies, in vitro invasiveness for human erythrocytes is nearly
abrogated [56]. B. bacilliformis also possesses an invasion-
associated locus comprised of two genes, ialA and ialB, that can
confer an invasive phenotype on Escherichia coli for human red
cells in vitro [82]. The ialA gene codes for a (di)nucleoside
polyphosphate hydrolase that may function to reduce stress-
induced dinucleotide ‘‘alarmones’’ encountered in the host cell
and therefore enhance pathogen survival [83]. The ialB gene
codes for a protein with similar molecular mass and considerable
amino acid sequence similarity to the adhesion and invasion locus
(Ail) protein of Yersinia enterocolitica [84] and the resistance to
complement killing (Rck) protein of Salmonella typhimurium [85].
Both Ail and Rck are implicated in host cell attachment, invasion,
and serum resistance. Whether IalA and IalB mediate or facilitate
invasion of other host cell types is unknown. A signature-tagged
mutagenesis study using B. birtlesii identified ialB as a gene
necessary to establish bacteremia in a mouse model. Moreover, the
ialB mutant strain displayed a reduced ability to invade
erythrocytes in vitro [75]. These results suggest that the ialAB
locus may be required for optimal intracellular invasion by many
Bartonella species.
A major difference between B. bacilliformis and other common,
pathogenic Bartonella species, such as B. henselae and B.
quintana, is the absence of VirB T4SS (Figure 6). VirB and the
coupling protein VirD4 constitute a machine that delivers T4SS
effectors (Beps) to the host cell’s cytosol. In turn, translocated Beps
subvert cellular functions, including: (1) rearrangement of the actin
cytoskeleton, leading to formation of and internalization by
invasomes [59,86]; (2) activation of a pro-inflammatory response
via NF-kB [87,88]; (3) inhibition of apoptosis [88]; and (4)
capillary sprout formation in endothelial cells cultured in a
collagen matrix [89]. During invasome formation, B. henselae are
contacted and moved rearward to form an aggregate on the
leading lamella of the endothelial cell. The bacterial mass is
subsequently internalized by membrane protrusions that are rich
in cortical F-actin, ICAM1, and phosphotyrosine. Chemical
inhibition studies suggest that invasome activity is actin-dependent
and microtubule-independent. Not surprisingly, B. bacilliformis
cannot trigger invasome formation because it lacks a VirB T4SS.
Intracellular growth
Bartonellae invade and multiply within cells of their natural
hosts. It is thought that seeding of the bloodstream occurs from a
primary niche, including the endothelium and migratory cells,
such as lymphocytes and phagocytes, or perhaps hematopoietic
progenitor cells [74,90]. Regardless, it appears that these bacteria
have increased intracellular growth rates [91]. This is puzzling,
considering the absolute requirement of bartonellae for heme and
the iron-limiting nature of the intracellular niche. Two indepen-
dent systems have been described whereby bartonellae bind and
transport heme. The hemin-binding proteins (Hbp’s) are a group
of porin-like, beta-barrel proteins that are surface-exposed [92,93].
Hbp’s are encoded by paralagous gene families [94], and the
number of genes varies among species (ranges from three hbp
genes in B. bacilliformis to eight in B. australis). B. bacilliformis
encodes three closely linked, tandem hbp genes (e.g., BAR-
BAKC583_1213-1215 and BbINS_05732, 05727, and 05722).
Several roles for Hbps have been proposed, including: (1) coating
of the bacterium with heme to serve as a nutritive reservoir [93],
(2) providing a heme-based antioxidant barrier against reactive
oxygen species [93], (3) decreasing oxygen levels around the
bacterium to provide a more favorable microaerophilic environ-
ment [93,95], and (4) serving as an adhesin to bind fibronectin,
heparin, and HUVECs [96].
Figure 7. Scanning electron micrographs of deformin-induced invaginations and pits on erythrocyte membranes. B. bacilliformis
colonization of cell membrane deformations is readily apparent. Reprinted by permission from [34].
doi:10.1371/journal.pntd.0002919.g007
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Bartonella species also employ a more typical hemin utilization
(Hut) system consisting of a hemin receptor, an ABC transporter
(including a permease, ATPase, and a periplasmic heme-binding
protein) and a cytosolic heme-degrading/storage protein [97]. In
B. quintana and B. henselae, the tonB gene is located immediately
upstream and in opposite orientation to the hut locus and encodes
TonB, a protein that energizes outer membrane processes,
presumably including Hut-mediated heme transport. Interestingly,
B. bacilliformis lacks an obvious TonB homologue, begging the
question as to the nature of its functional surrogate (note: ExbB
and ExbD are found in all three bacteria). Regulation of the hut
locus is accomplished through the iron response regulator (Irr) and
promoter regions containing an H-box, a motif known to interact
with Irr [97]. Other than Irr’s involvement, the hemin transport
system in Bartonella species is remarkably similar to those of other
gram-negative bacteria.
B. bacilliformis is generally accepted as nonhemolytic on blood
agar. However, incomplete b-hemolysis can be observed on thin
blood agar plates that are cultured for at least four days. The
hemolysin is extracellular and can pass through 0.2 mm filters into
underlying medium, where it produces a hemolytic zone that
silhouettes the colony’s shape [98]. A similar, incomplete b
hemolytic activity with a delayed appearance (four days’ growth)
was also observed with B. elizabethae [99]. Finally, a contact-
dependent hemolysin has been described from B. bacilliformis that
is proteinaceous, requires prolonged incubation periods, acts
independently of deformin, and is most active at 37uC [100]. The
molecular nature of the hemolysins and their potential role in
virulence have not been investigated thoroughly, to date. It is
tempting to speculate that hemolysins participate in escape from
vacuoles and cytosolic membranes of host cells.
Angiogenesis
The clinical manifestation and histological appearance of VP
are similar to bacillary angiomatosis (BA), a pathology that can
occur in immunocompromised individuals infected with B.
henselae or B. quintana [101–103]. VP and BA are characterized
by tumor-like lesions or nodules filled with immature capillaries
and swollen endothelium due to chronic colonization by bacteria
and infiltration of polymorphonuclear leukocytes and macrophag-
es [104,105]. BA caused by B. henselae has been observed
primarily on skin, although the bacteria can disseminate and affect
other organs such as eyes, liver, and heart [102,106]. In contrast,
VP lesions are rarely observed in organs other than skin and
subcutaneous tissue [10]. As in tumor angiogenesis, Bartonella-
triggered neovascularization follows a series of steps that involve
disruption of the normal pattern of the extracellular matrix and
basal membrane, endothelial cell migration and proliferation at
the site of angiogenic stimuli [107].
In an effort to study angiogenesis induced by B. bacilliformis,
early studies employed nonhuman primate models, including
rhesus monkeys [108]. Resulting angiogenic lesions varied
depending on the susceptibility of the monkeys as well as the
virulence capacity of the bacteria. Intradermal injection of young
rhesus monkeys with B. bacilliformis obtained from the blood of a
patient with a fatal case of OF gave rise to granulomatous nodules
filled with new capillaries similar to VP [47]. Nodules varied in
size (0.5–2 cm in diameter and 2–10 mm high), appeared at the
site of inoculation within three weeks, and increased in size until
60 days post-inoculation, where they remained stationary before
starting to regress [47]. The pathogen was readily found inside
angioblasts and endothelial cells of nascent capillaries. Noguchi
demonstrated that B. bacilliformis that had been passaged in
rhesus monkeys, as well as those that were taken from VP tissues
led to more severe clinical manifestations of infection [109]. In
those test animals, numerous miliary, cherry-red verrugae
appeared within one week around the site of inoculation
(eyebrows) and were scattered over remote areas such as the
groin and legs.
Despite these initial studies, there are few reports describing the
molecular basis of B. bacilliformis–induced angiogenesis. This is
largely due to the lack of an inexpensive in vivo animal model.
Although BALB/c mice resist infection by B. bacilliformis [110], a
SCID/BEIGE murine model for studying Bartonella infection
may prove useful, but has not been tested in this regard [111].
Garcia et al. investigated the effect of B. bacilliformis extracts on
human endothelial cells in vitro as well as in an in vivo model of
angiogenesis consisting of subcutaneous implantation of sponge
discs containing bacterial extracts into adult Sprague-Dawley rats
[103]. The study revealed that a mitogenic factor in bacterial
extracts caused vascular proliferation in a dose-dependent
manner. However, this factor did not induce a pro-inflammatory
response as it did not lead to an increase in the number of
phagocytes and lymphocytes. A subsequent report found that B.
bacilliformis GroEL had mitogenic activity toward endothelial
cells undergoing serum starvation-induced apoptosis [112], but it
did not affect caspase 3 activity. B. henselae was also shown to
stimulate endothelial cell proliferation, but to a much lesser extent
than B. bacilliformis extracts [112]. Subsequently, GroEL of B.
henselae was found in a secreted fraction of the bacterium and
caused endothelial cell proliferation and acted by triggering release
of intracellular calcium stores [113]. It is possible that GroEL of
both species functions as a chaperonin to stabilize a yet
unidentified mitogenic factor. However, in contrast to B.
bacilliformis, an extract from B henselae was shown to have an
anti-apoptotic factor that reduced apoptosis of endothelial cells by
inhibiting caspase 3 and caspase 8 activities [114]. Interestingly,
the anti-apoptotic activity was enhanced in the presence of live
bacteria.
Our current understanding of Bartonella-induced angiogenesis
suggests the process involves at least three mechanisms that work
synergistically: (1) mitogenic triggering of endothelial cell prolif-
eration, (2) inhibition of apoptosis (contact-dependent or indepen-
dent), and (3) angiogenic reprogramming of infected host cells
(with pro-inflammatory activation of cytokines) [67,103]. Analysis
of VP lesions revealed that infection induces production of VEGF,
VEGFR1, VEGFR2, and angiopoietin-2 transcripts [115]. Inter-
estingly, endothelium was shown to produce very little VEGF,
whereas overlying epidermis was the major source of VEGF. To
our knowledge, the mechanism whereby B. bacilliformis induces
production of these pro-angiogenic factors has not been investi-
gated, to date. Expression of hypoxia-inducible factor 1 (HIF-1)
and subsequent induction of VEGF have been well documented in
tumor angiogenesis [116,117].
B. henselae infection studies using in vitro cell culture models
and BA tissues showed that bacteria induced HIF-1 activation and
VEGF secretion [68,69]. This angiogenic response was shown to
be dependent on expression of BadA and its interaction with b1-
integrin mediated by fibronectin binding [62]. Moreover, B.
henselae infection was shown to trigger a VirB/Bep-dependent
angiogenic phenotype in human endothelial cell models. This
includes inhibition of endothelial cell apoptosis and a robust
induction of capillary sprout formation mediated by BepA
[89,118], and NF-kB-dependent stimulation of a pro-inflamma-
tory response leading to production of IL-8, expression of adhesion
molecules such as E-selectin and ICAM-1, and up-regulation of
macrophage chemoattractant protein-1 (MCP-1) [105,119]. It is
reasonable to speculate that B. bacilliformis does not display
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effector protein-dependent cell proliferation or anti-apoptotic
activity, because it lacks a T4SS. Nevertheless, it may be of
interest to determine if B. bacilliformis Brps are involved in
interaction with b1-integrin and elucidate what role they might
play in inducing a pro-angiogenic response.
Host immune response, protection
Lymphadenopathy is a frequent complication. Immunosup-
pression is a common manifestation of B. bacilliformis infection
and probably results from acute anemia and leukocytosis. In fact, a
compromised immune state is thought to contribute to the
increased incidence of secondary infections seen in infected
individuals.
Lifelong humoral immunity apparently results from a B.
bacilliformis infection [2,120]. In endemic areas, up to approxi-
mately 60% of the population can be seropositive (mainly IgM
isotype), and many of these individuals are healthy [121].
Nevertheless, seropositive people who are asymptomatic or post-
eruptive for verrugae are often blood culture–positive for B.
bacilliformis [122]. An extraordinary carrier rate, up to 15%, has
been reported in some areas of Peru [123], and it is this infected
population that presumably serves as the reservoir [1,3,77]. An
inverse correlation between patients’ chronological age and
incidence or disease severity in endemic regions suggests that
humoral immunity, as a result of recurring or chronic infections,
confers partial immunological protection [24,36]. Because barto-
nellae are found in various body fluids and cells, participation by
both humoral and cellular arms of the immune system would
undoubtedly need to be invoked to resolve the infection. However,
for unknown reasons, this does not occur in many afflicted
individuals, and the infection is persistent.
Phylogeny and Genomics: Clues to the Evolution
of B. bacilliformis
Bartonella comparative genomics
Bartonella genomes consist of single, circular chromosomes
ranging in size from 1.45 Mb in B. bacilliformis to 2.64 Mb in B.
tribocorum, and are largely collinear with a Guanine+Cytosine
(GC) content of 38%–42% [124]. Adenine+Thymidine (AT)-
richness of these genomes is a universal attribute of host-associated
bacteria. Several Bartonella species also harbor circular plasmids
[125–128], although none have been reported for B. bacilliformis.
The relatively small size of Bartonella genomes is a common
attribute among endosymbionts and host-associated bacteria, and
possibly reflects genome reduction as a result of decreased
selection pressure in the intracellular niche and in the context of
a narrower range of hosts [129]. It appears that the number of
vertically inherited genes within Bartonella genomes is relatively
consistent (approximately 1,000), but the number of horizontally
acquired (imported) genes varies significantly; thus the genomes of
species such as B. tribocorum and B. grahamii, which both exceed
2 Mb, contain more than 400 imported genes, whereas those of
species such as B. bacilliformis and B. quintana, which are 1.45
and 1.6 Mb respectively, contain 150 or fewer imported genes
[127].
Comparative genomics has been used to survey the distribution
of coding sequences in extant Bartonella species, then correlate
this distribution to the phylogenetic juxtapositions of these species
as a means to infer patterns of gene acquisition and loss during
evolutionary radiation of the genus [124,130]. The focus of
considerable interest is on genes encoding virulence factors that
mediate interactions with the host, such as the virB and trw gene
clusters and numerous others described elsewhere in this review, as
they are likely key determinants of both host specificity and
divergent modes of parasitism that characterize the genus
(Figure 6).
Taxonomy/phylogeny of the genus
The genus Bartonella was proposed almost a century ago by
Strong to accommodate B. bacilliformis, following its description
in red blood cells of OF patients by Alberto Barton in 1909 [131].
The advent of 16S rDNA sequencing in the late 1980s suggested
that B. bacilliformis was genetically similar to the trench fever
agent, then called Rochalimaea quintana [132], and also a newly
emerging pathogen that was subsequently named Rochalimaea
henselae [133,134]. The genera Bartonella and Rochalimaea were
later unified with one another [135] and with the genus
Grahamella [136], taking the name of the longest established
taxon, Bartonella. Over the past 13 years, the genus has gradually
expanded, such that it now includes 31 ‘‘validated’’ species and
subspecies (http://www.bacterio.net/index.html) along with many
more informal taxa and partially characterized strains. B.
bacilliformis is the type species of the genus.
Phylogeny of the genus remains somewhat unresolved. The
evolutionary relationship of Bartonella to Brucella and other
genera within the Agrobacterium/Rhizobium group of a-proteo-
bacteria is well established, but delineation of clusters of species
within the genus remains somewhat uncertain. The value of intra-
genus phylogenetic inference derived from 16S rDNA alignments
was limited due to its conservation amongst Bartonella species
[137,138], thus alignments of other loci have been more frequently
exploited. The first of these to be widely adopted was gltA [139],
and phylogenetic inference derived from this locus indicated that
B. bacilliformis was the most outlying species, in a lineage deeply
divergent from other members of the genus. Phylogenies derived
from ftsZ, groEL, and rpoB genes also inferred this peripheral
position for B. bacilliformis [140]. However, the advent of
phylogenies derived from alignment of concatenated sequence
data from multiple loci cast doubt on B. bacilliformis’ position as
an outlier. Reconstructions by Gundi et al. [141] strongly
supported a specific evolutionary relationship with Bartonella
clarridgeiae, a position that was reaffirmed by Inoue and
colleagues in 2010 [142]. This study also inferred that B.
bacilliformis and B. clarridgeiae lay within a well-supported
cluster that also contains B. birtlesii, B. bovis, B. capreoli, B.
chomelii, and B. schoenbuchensis.
Whole genome sequence (WGS) data of several Bartonella
species have now been released, and those of many more are either
in draft form or in progress at this writing. Among these, a
complete genome is available for one B. bacilliformis strain
(KC583), whereas data in the form of contigs have been released
for a second strain (INS), and projects on nine other strains are
currently in progress (http://www.ncbi.nlm.nih.gov/genome/
genomes/524). WGS data are being increasingly used to infer a
robust phylogeny amongst Bartonella species.
Engel and colleagues [130] generated concatenated sequences
from 478 loci within genomes of representatives of eight
Bartonella species (B. bacilliformis, B. clarridgeiae, B. grahamii,
B. henselae, B. quintana, B. rochalimae, B. shoenbuchensis, B.
tribocorum, and two unnamed taxa), and from their alignment
inferred a phylogeny with four lineages, where B. bacilliformis is in
a lineage separate from all other Bartonella. Most recently, Guy
and colleagues [124] described two new, fully resolved genomes
(B. australis and B. vinsonii subspecies berkhoffii) and four near-
complete genomes (B. bovis [2 isolates], B. vinsonii subspecies
berkhoffii, and B. schoenbuchensis). The group then compared 428
orthologous core genes amongst the 16 Bartonella taxa described
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above. This phylogeny conflicted with that proposed by Engel et
al. [130], in that B. australis rather than B. bacilliformis, was the
earliest diverging species and that B. bacilliformis clustered with B.
bovis and B. schoenbuchensis. Subsequent addition of WGS data
for an isolate of an informal taxon referred to as ‘‘Bartonella
tamiae’’ to this dataset and a revision of the genes included did not
result in a repositioning of B. bacilliformis within the inferred
phylogeny, although ‘‘B. tamiae’’ replaced B. australis as the
earliest diverging species [124].
Placement of B. bacilliformis within a cluster containing B. bovis
and B. schoenbuchensis, rather than the earliest diverging species
of the genus, has led to reevaluation of hypothetical evolutionary
processes that have shaped Bartonella genomes. The small
genome size of B. bacilliformis could be explained by reductive
genome evolution following a recent host switch; a model akin to
that proposed for B. quintana [143]. As all other members of the
cluster containing B. bacilliformis are ruminant-associated, it has
been proposed that B. bacilliformis descended from an ancestral
strain that successfully made a host shift from ruminants to
humans [124]. The alpaca (Vicugna pacos) and the lama (Lama
glama), the two most common domesticated ruminant species in
the endemic region, are perhaps a source of this ancestral strain.
Domestication of these ruminants began some 6,000 years ago,
providing a time frame for a hypothetical B. bacilliformis host-
shift.
Genetic diversity among B. bacilliformis strains
Few studies exploring the genetic diversity of B. bacilliformis
have been published [144,145]. These studies employed a variety
of different typing methods, including pan-genomic approaches
such as amplified fragment-length polymorphism and infrequent
restriction site PCR, and/or comparison of nucleotide sequences
at loci including gltA, ialB, and, most frequently, the 16S–23S
rDNA internal transcribed spacer (ITS). All these approaches have
delineated genotypes within the species and have been useful in
characterizing the molecular epidemiology of bartonellosis
[144,145]. Most recently, a multilocus sequence typing (MLST)
scheme was developed for B. bacilliformis [146]. Application of
this procedure to 46 isolates collected in Peru yielded interesting
findings. Perhaps the most significant was that B. bacilliformis may
not be a single species; the MLST data provided clear evidence
that two isolates recovered from patients with OF had diverged
from other B. bacilliformis isolates. These isolates are therefore
likely members of a novel Bartonella genospecies. The two
divergent isolates were not epidemiologically linked (i.e., they were
obtained nine years apart and from locations that lie 150 km from
one another). Furthermore, two additional isolates that are also
potential members of this new genospecies have been encountered
elsewhere [10]. Taken together, results suggest that novel B.
bacilliformis-like genospecies have a wide distribution in Peru. The
study by Chaloner et al. [146] delineated eight genetic lineages
among the isolates surveyed and, in line with many previous
studies, these lineages correlated to some degree with the
epidemiological provenance of isolates. Thus, strains associated
with new foci of Carrión’s disease clustered together and were
distinct from the most common genotypes, which were encoun-
tered across endemic regions of Peru. However, extrapolation of
these data to explore the general epidemiology of Carrión’s disease
may be somewhat premature given the relatively small size and
opportunistic nature of the collection examined. This shortfall can
only be accurately addressed with systematic surveys, although
MLST appears to be an appropriate genotyping method to
employ if such studies can be instigated.
In an effort to explore more comprehensively the extent of
genetic variation among B. bacilliformis strains, we compared the
KC583 WGS with genome sequence data available in the form of
contigs for the INS isolate (the only genomic data currently
available for another B. bacilliformis strain [147]), using progres-
sive Mauve (pM). A total of 20 contigs, containing approximately
1,444,079 base pairs of data, were analyzed. Remarkably, our
efforts revealed the two datasets differed by only 27 single-
nucleotide polymorphisms (SNPs), with no evidence of any indels
or repeat motifs. We mapped the position of these 27 SNPs,
finding that 19 lay in putative open reading frames. Of these, 13
were nonsynonymous and two introduced a stop codon. Taken
together, these observations indicate that the two B. bacilliformis
strains, despite sharing no specific epidemiological relationship
(being isolated roughly 50 years apart from patients inhabiting
geographically remote locations) possess, for all intents and
purposes, indistinguishable genomes. Such is the extraordinary
nature of these findings that their credibility must be questioned;
the upcoming release of genomic data from an additional nine B.
bacilliformis isolates will provide a broader insight into intraspecies
genomic diversity and put the results described above into better
context.
Diagnostics and Identification
Diagnostic symptoms of OF include an extraordinarily low
erythrocyte count (approximately 500,000/mm3) [33,77,148] and
numerous infected erythrocytes in blood smears prepared with
Wright’s, Giemsa, or eosin/thiazine stains [32,121] (Figure 1A).
Blood smears have served as a standard diagnostic tool for
Carrión’s disease for decades, due to low cost and ease of use.
However, the test suffers from low sensitivity, despite its high
specificity [4]. Diagnoses can also be made based on blood culture,
PCR, immunological tests, or a combination thereof (see below).
Diagnosis of VP is made by the occurrence of cutaneous
angiomatous skin lesions. As in BA, the histopathology of verrugae
reveal bacteria, albeit with difficulty [40], when sectioned and
stained with Warthin-Starry silver stain [149] or Giemsa stain
[32]. A patient’s age (especially ,5 years old) and whether
bartonellosis has recently occurred within the family are also useful
predictors of a B. bacilliformis infection [24].
Growth requirements and physiology
Bartonellae can be isolated from patient blood by preparing
samples with a lysis-centrifugation method [150] or a freeze-thaw
protocol [151]. Primary isolates of Bartonella species have also
been obtained using a BACTEC blood culture system (Becton
Dickinson) and Bartonella alphaproteobacteria growth medium
(BAPGM) [152,153]. Homogenized tissues may also be used as an
inoculum for blood plates or endothelial cell monolayers [154].
The slow growth rate of B. bacilliformis (approximately7-hour
generation time in vitro [34]) can complicate identification and
requires that isolates be cultured several days to visualize colonies.
Most bartonellae are microaerophilic, capnophilic (5% CO2), and
grown at approximately 37uC, whereas B. bacilliformis requires
cooler temperatures (25uC–30uC) and ambient CO2 for culture. In
addition, humidity of the incubator should be near 100%. Like
other Bartonella species, B. bacilliformis cannot synthesize
protoporphyrin IX (PPIX) or heme (Fe2+-PPIX), and the essential
nutrient is obtained from hemin (Fe3+-PPIX), hemoglobin, and
host erythrocytes. Interestingly, Bartonella cannot utilize heme-
rich scavenger molecules of the host, such as lactoferrin or
transferrin, unlike many pathogens. Commonly used growth
media for Bartonella species include chocolate agar, hemin agar,
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or various blood agars (for recipes, see [155]). The basal medium
of these formulations varies and includes Brucella medium,
trypticase soy, GC, heart infusion, or Columbia agars. Media
supplements often include erythrocytes (sheep, rabbit, etc.),
hemoglobin, IsoVitalex (Becton Dickinson), and serum (sheep).
The medium should be pH 7.0–7.5 for optimal growth.
Colony and cellular morphology, structure
B. bacilliformis is a gram-negative, non–acid fast, pleomorphic
coccobacillus. Bacteria stain well with Giemsa or Gimenez stains.
Most cells measure 0.5 mm wide by 1.0 mm long. Electron
micrographs of B. bacilliformis are shown in Figure 5. B.
bacilliformis colonies are typically very small (initially pinpoint
but growing to 0.2–1 mm in diameter after several days), round,
and lenticular with an even margin and a raised center in older
colonies, and range from translucent to opaque. Although colonies
from primary isolates can take weeks to become visible, growth is
much more rapid (three to seven days to maximal size) in
subsequent passages. Colony color can vary on different media but
is typically clear to creamy white. B. bacilliformis is highly motile
by unipolar, lophotrichous flagella, a phenotype shared with B.
clarridgeiae and B. rochalimae [39,56,156]. Twitching motility, as
observed in low-passage B. henselae and B. quintana [58,134], has
not been reported. Capsules and endospores are not present in B.
bacilliformis, in keeping with other Bartonella species.
On the whole, the cellular architecture and composition of
bartonellae are typical of gram-negative bacteria [157]. Notable
exceptions include the unusual cellular fatty acids (CFAs) (see
‘‘Cellular Fatty Acid Analysis,’’ below) and architecture and
immunogenicity of its lipopolysaccharide (LPS). A ‘‘deep rough’’
LPS chemotype (little if any O-chain polysaccharide is present),
was first reported for B. bacilliformis [158,159]. Later, similar
chemotypes were reported for B. quintana [160] and B. henselae
[161]. Further investigation of B. henselae’s LPS showed that it
contains a unique inner oligosaccharide core of two keto-
deoxyoctulosonic acids (KDOs) and one glucose molecule [161].
Its pentaacyl lipid A backbone is also unusual; instead of the
typical glucosamine sugars, it contains 2,3-diamino-2,3-dideoxy-
glucose dissacharide (GlcN3N) with both sugars phosphorylated.
Interestingly, lipid A of B. henselae’s LPS possesses a long-chain
fatty acid (C26:0 or C28:0) similar to other intracellular pathogens,
including Legionella and Chlamydia species [161]. It is tempting to
speculate that B. henselae’s LPS is representative of all Bartonella,
especially considering the uniform LPS chemotype for the genus.
Finally, work has shown that Bartonella endotoxin is considerably
less toxic relative to LPS from other gram-negative bacteria, and
its activation of TLR-4 pathways is significantly (1,000–10,000-
fold) lower than Salmonella’s LPS [161]. In fact, recent work has
shown that B. quintana LPS is a potent antagonist of TLR-4-
mediated activation of human monocytes by E. coli LPS [162].
Whether a relatively low level of endotoxicity and TLR-4
antagonist activity holds for B. bacilliformis’ LPS is unknown,
but would not be surprising.
The cellular and subcellular protein content of Bartonella
species has been analyzed by several groups over the years. Early
work showed that the B. bacilliformis outer membrane fraction
contains 14 proteins of 11.2 to 75.3 kDa in mass [159], as
compared to nine surface-exposed proteins in B. henselae [163].
The proteomes of whole cells and subcellular fractions of B.
quintana and B. henselae have been analyzed by two-dimensional
gel electrophoresis and MALDI-TOF-MS of the protein spots. For
example, two studies identified 44 [164] and 53 [165] proteins
associated with the B. henselae outer membrane fractions. A third
study analyzed the B. quintana membrane subproteome and
found 60 proteins [166]. Finally, analysis of B. henselae’s total
proteome identified 191 different proteins (431 spots) [167].
Unfortunately, a comprehensive analysis of the B. bacilliformis
proteome has not been done, to date.
Biochemical tests
Bartonellae are nonfermentative, aerobic (microaerophilic)
bacteria with a relatively unremarkable physiology. Thus,
conventional biochemical tests are not particularly helpful in
presumptive identification of species. One problem with using
standard biochemical tests on Bartonella species is that hemin is
normally not included in the medium, and results must be judged
cautiously. Notwithstanding this caveat, standard biochemical tests
show that B. bacilliformis is strictly aerobic and does not utilize
carbohydrates by preformed or de novo enzymes. Tests for
oxidase, Voges-Proskauer, catalase, indole production, nitrate
reduction, urease activity, hippurate hydrolysis, succinate, alkaline
phosphatase, tetrathionate reductase, pyrazinamidase, tributyrin,
o-nitrophenyl-b-D-galactoside, esculin hydrolysis, and arginine
dihydrolase are all negative [136,156,168,169]. However, tests for
peptidase activity on L-proline and L-lysine (acid) are useful in
presumptive, differential identification of B. bacilliformis, which is
negative for proline and positive for lysine utilization
[136,156,168,170]. Screens are typically done in multitest formats
designed for anaerobes, such as the MicroScan Rapid Anaerobe
identification panel (Dade Behring).
Polymerase chain reaction (PCR)
PCR is sensitive and specific for identifying Bartonella species
and can be used to confirm a presumptive identification. PCR can
be done directly on affected tissues and/or blood or on enrichment
cultures [171,172]. In early work, PCR was used to amplify the
16S rRNA gene or fragments to generate a sequencing template.
Resulting data were compared to known 16S rRNA gene
sequences [154,173–175]. However, the utility of the 16S RNA
gene as a means of differentiating Bartonella species was limited
due to conservation [137,138]. More useful PCR-based strategies
for genus and species identification have been described for serine
protease (htrA) [176], gltA [139,177], divisome protein (ftsZ)
[178], riboflavin synthase (ribC) [179], NADH dehydrogenase
gamma subunit (nuoG) [180], heme-binding protein A/Pap31
(hbpA/pap31) [181], tmRNA (ssrA) [182], RNA polymerase beta
subunit (rpoB) [183], and the 16S–23S rRNA ITS [138,184]. One
recent report employed PCR, with rpoB as the target, and
pyrosequencing of the resulting amplicons for rapid species
identification, including B. bacilliformis [185]. Another used ialB
as a PCR target and showed high sensitivity and specificity in 15
patients with OF [186]. Finally, a recent study demonstrated the
utility of collecting dried-blood spots from patients in endemic
areas, followed by quantitative PCR (qPCR). Results showed that
24.6% of 65 children studied were positive by qPCR on spots,
whereas only 3% were blood-culture positive [187].
Cellular Fatty Acid (CFA) analysis
CFA analysis by gas chromatography has been used to identify
Bartonella to the genus level. This is made possible by the group’s
atypical fatty acid composition. For example, predominant fatty
acids of bartonellae include cis-11-octadecanoic acid (C18:1v7c)
(approximately 54%) and hexadecanoic acid (C16:0) (approximate-
ly 20%). However, B. bacilliformis is unusual in that it contains
little octadecanoic acid (C18:0) (approximately 2%) compared to B.
elizabethae, B. henselae, B. clarridgeiae, and B. quintana
(approximately 20%). B. bacilliformis also has an unusually high
amount (approximately 20%) of cis-11-hexadecanoic acid
PLOS Neglected Tropical Diseases | www.plosntds.org 13 July 2014 | Volume 8 | Issue 7 | e2919
(C16:1v7c) relative to other Bartonella species (typically ,1%)
[99,150,156,188,189].
Immunological tests
Immunological tests are, for the most part, sensitive and specific
for Carrión’s disease. However, positive results must be judged
cautiously, as they may not indicate an active infection, but rather
a persistent humoral immune response. The indirect fluorescence
antibody (IFA) test has been used as a specific and sensitive
diagnostic tool [190]. In addition, recent work with ELISAs
containing recombinant LppB (43-kDa lipoprotein) showed a high
degree of sensitivity and specificity in 27 confirmed patients with
either chronic or acute disease [191]. Finally, an immunoblot-
based protocol incorporating proteins from sonicated B. bacilli-
formis showed good sensitivity with sera from ten cases of acute
disease and very high sensitivity using sera from 32 cases of
chronic disease [192]. Likewise, work by Maguiña et al. showed a
high degree of sensitivity in immunoblots probed with nine and 11
sera from patients with acute and chronic disease, respectively
[193,194]. It is clear that immunological tests are useful diagnostic
tools for Carrión’s disease, especially when combined with other
techniques such as PCR and blood culture. However, immuno-
diagnostics for this disease are relatively underdeveloped.
Current Status of Treatment, Prevention and
Control
Syndrome-dependent courses of therapy
Analysis of antimicrobial susceptibilities of four strains of B.
bacilliformis showed that the bacterium is extremely sensitive to a
wide array of drugs in vitro, including aminoglycosides, beta-
lactams, macrolides, tetracyclines, fluoroquinolones, chloram-
phenicol, clorimoxazole, and rifampin [195]. However, outcomes
of antimicrobial therapy in patients with Carrión’s disease have
not been as clear-cut because of several confounding factors,
including patient history, immunosuppression, frequent secondary
infections, and persistent or recurring bartonellosis despite
therapeutic intervention.
Antimicrobial therapy for Carrión’s disease is predicated on
whether disease is acute or chronic. Acute disease has been treated
with chloramphenicol for decades [2,14,193,196–199], sometimes
in combination with other antimicrobials [193]. One apparently
effective mixture is chloramphenicol plus a beta-lactam [197]. The
choice of chloramphenicol was undoubtedly made popular due to
its effectiveness, low cost, and broad spectrum of activity against
common co-infectious agents, such as salmonellae [37,193].
Tetracyclines (doxycycline), beta-lactams (ampicillin, penicillin
G), macrolides (erythromycin, roxithromycin), trimethoprim-sul-
famethoxazole, and fluoroquinolones (norfloxacin, ciprofloxacin)
have been used as alternatives to treat OF [15,41,196,197].
Although ciprofloxacin holds great promise for treating acute
cases, it should be used judiciously, as resistance mutants arise
rapidly in vitro [200,201], and intrinsic resistance to the drug has
been reported in strains that were obtained prior to widespread
use of fluoroquinolones [202]. Interestingly, in addition to
antimicrobial therapy, blood transfusions have been employed
for treating severe anemia of OF [36,203].
Chronic disease is usually treated with rifampin, although
streptomycin is also effective and was the drug-of-choice prior to
1975 [5,193,197,199]. Of note is that VP does not respond to
either chloramphenicol or penicillin treatment [15,32]. Ciproflox-
acin, azithromycin, and sultamicillin, combined with deflazacort,
have been used as alternatives to treat VP [4,5,204].
Prevention and control measures
No vaccine is currently available for B. bacilliformis. Early work
investigated a composite vaccine prepared from four strains of the
bacterium that were grown axenically and formalin-inactivated
(0.4% formalin in physiological saline) [205]. Immunizations were
administered (one to three times subcutaneously) to 22 men
stationed for one month at a Peruvian military outpost located in
the ‘‘verruga zone’’’ near Matucana, Peru. Nineteen of the men
seroconverted during the study. Twelve men (55% of test group)
became blood-culture positive over the course of exposure and
eventually presented with symptoms of bartonellosis that were, for
the most part, relatively mild. Unvaccinated control groups, prior
to and after the study, showed approximately 75% (anecdotal) and
90% infection rates, respectively, with many incapacitated due to
severity of illness [205]. Although preliminary in nature, this pilot
study suggests that antibodies generated against formalin-killed B.
bacilliformis reduce disease severity in humans but do not provide
full protection against infection. Reasons for the partial protection
are unclear, but may be due to strain-specific antigenic variation, a
humoral immune response bias against the vaccine formulation, or
modification of important protective antigens by formalin cross-
linkage.
In the absence of a vaccine, control of the sand fly vector has
been the fallback course of action in endemic areas. As early as
World War II, Peruvian army personnel were provided with bed
nets and given Vaseline-citronella ointments as a means of
warding off sand flies [205]. Early work in endemic areas of Peru
showed that DDT insecticide (5% w/v in kerosene) sprayed in
and around dwellings was effective at killing sand flies and kept
the insects at very low levels for up to four months [206]. The
reduction of sand fly numbers ‘‘to the vanishing point’’ using
DDT also correlated to a ‘‘virtual cessation of bartonellosis’’ in
construction camps within endemic areas of Peru, although exact
numbers were not reported [206]. More recent, unpublished
results of sand fly control using residual pyrethroid insecticides in
homes near Ancash, Peru are promising, as the duration of
control was increased to a year (as reported in [4]). Moreover,
others have reported good success with residual pyrethroids
against old-world sand flies [207]. In any case, control measures
using insecticides may prove to be challenging, especially
considering that Lutzomyia larvae develop in largely unknown
terrestrial habitats, and adult flies, when not resting in houses or
animal sheds, dwell in deep cracks and crevices during daylight
hours; sites that are not readily accessible to superficial
application of insecticides.
In Colombia, other interventions including pyrethroid-
impregnated bednets and curtains were used as practical
means of controlling sand flies entering houses [208]. In Italy
and Burkina Faso, permethrin-impregnated curtains reduced
the numbers of endophilic phlebotomine sand flies by 90% and
95%, respectively [209,210]. However, because peak biting
activity occurs shortly after sundown and prior to the time
when human inhabitants usually retire for the night, impreg-
nated bednets and curtains may have minimal effect in
interrupting sand fly–to–human transmission [211]. Further-
more, it has been shown that sand flies can pass through the
mesh of an impregnated bednet and bite a host before
succumbing to insecticide exposure (Personal communication,
Dr. Edgar Rowton, unpublished data). Nevertheless, if the use
of impregnated bednets and curtains can shorten the lives of
sand flies, and thereby suppress the vector population, the risk
of infection may be reduced [211]. Varying results of field
studies dictate the need for trials against specific target vectors
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before adopting this type of intervention as a means of control
for B. bacilliformis vectors.
Field trials conducted in Israel and Kenya showed that sand flies
will feed on sugar sprayed on plants in the flies’ natural habitats,
suggesting a possible means for controlling sand flies with toxic
baits [212]. This finding prompted a pilot study in Kenya to
control sand flies resting in rodent burrows and eroded termitaria
by spraying vegetation with sugar solution containing Bacillus
sphaericus and a dye to reveal that the flies had fed on the sugar
[213]. Marked flies were caught entering the rodent burrows and
termitaria, and the number of flies emerging from the rodent
burrows declined significantly [213]. More recently, scientists at
Louisiana State University evaluated several chemical insecticide-
treated sugar baits and concluded that they could be efficacious in
controlling adult sand fly populations with targeted use in specific
habitats [214].
In many foci, sand flies are closely associated with rodents and
have been recovered entering and exiting rodent burrows
(personal observation, PGL). Burrows of many rodents are the
suspected habitats of the immature stages [215]. In fact, sand fly
larvae have been observed feeding on rodent feces inside a
burrow [216]. Both adult and immature stages benefit from the
microhabitat created within rodent burrows [211]. Recently,
novel research has focused on sand fly control methods that
capitalize on the close ecological interaction between sand flies
and rodents. Feed-through or systemic insecticides such as
ivermectin or spinosad incorporated into rodent baits have been
shown to cause 100% mortality of bloodfeeding sand flies for at
least one week [217,218]. In follow-on studies, it was shown that
rodents fed on fipronil produced feces that were toxic to
coprophagous larvae for up to 21 days. An approach using
rodent baits containing fipronil could significantly suppress
vector populations that originate in the vicinity of rodent
populations, eliminating the portion of the adult population that
feeds on the rodents and immature stages that feed on the toxic
feces [219].
Future Prospects
In many respects, Carrión’s disease is a ‘‘poster-child’’ for
neglected tropical diseases. The illness is endemic to remote, rural
areas of South America, and afflicted populations are typically
indigent and lack ready access to transportation, modern means of
communication, and healthcare. Not surprisingly, few people
outside the Andes region are even aware of the disease and the
potential public health crisis posed by its spread. Climatic change
and vectoring of Carrión’s disease by alternate sand fly vectors
have undoubtedly contributed to the spread and re-emergence of
B. bacilliformis. While immediate remediation of climate change is
not realistic, improved sand fly control measures in and around
homes, especially during the rainy season, and enhanced
surveillance and formation of a multinational database to follow
the epidemiology of Carrión’s disease in endemic and proximal,
nonendemic areas of South America is achievable and clearly
warranted. Once identified, an adequate response to the outbreak
will require more effective-yet-inexpensive diagnostics that can be
done rapidly in rural settings with minimal training and modest
laboratory equipment. Solid-phase immunodiagnostics (e.g.,
ELISA, fluorescence microscopy) seem especially well suited for
development in the near-term and could be used in tandem with
blood smears to rapidly diagnose Carrión’s disease. Patient
samples (e.g., dried blood spots as in [187]) could then be
submitted to regional reference labs for confirmation of presump-
tive identification using blood culture and/or PCR-based tech-
niques. Fortunately, once B. bacilliformis is diagnosed, it is
susceptible to several antimicrobials and treatable. Nevertheless, in
view of the logistic problems surrounding patient inaccessibility to
healthcare, communication, and transportation to urban areas, the
development of a protective vaccine is clearly warranted. To this
end, both B- and T-cell epitopes of B. bacilliformis must be
identified to allow for the generation of a protective, multivalent
subunit vaccine that invokes both humoral and cellular immune
responses. The human-restricted reservoir and infection bode well
for the vaccine-mediated eradication of Carrión’s disease. The key
Key Learning Points
N B. bacilliformis is a sand fly–vectored bacterium respon-
sible for an emerging infectious disease of humans that
is endemic to South America.
N B. bacilliformis is the most virulent Bartonella species and
causes two disparate syndromes; a life-threatening,
acute infection of erythrocytes (OF) and a comparatively
benign, chronic infection of the vascular endothelium
(VP).
N The genome of B. bacilliformis has undergone extensive
reduction in response to specialization related to its
human-only parasitism and reservoir.
N Virulence determinants are understudied but include
adhesins (e.g., Bartonella repeat proteins), flagella, a
deformation factor for erythrocyte membranes (defor-
min), an invasion-associated locus encoding two pro-
teins (ialAB), a mitogenic protein that may facilitate
angiogenesis, and two heme-acquisition systems (Hut
and Hbp’s).
N Improved diagnostics, better sand fly control measures,
enhanced monitoring and surveillance for outbreaks,
and a protective vaccine are urgently needed to control
Carrión’s disease in South America.
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Serodiagnosis of Bartonella bacilliformis infection by indirect fluorescence
antibody assay: test development and application to a population in an area of
bartonellosis endemicity. J Clin Microbiol 38: 4269–4271.
191. Padilla C, Gallegos K, Marcelo A, Chenet S, Baldeviano C (2006) Expresión y
seroreactividad de la lipoproteı́na recombinante de 43-kDa de Bartonella
bacilliformis. Rev Peru Med Exp Salud Publica 23: 182–187.
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